Jim Simons Scopus Bio Pharma Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $0.45 $16,042 - $31,386	-69,748 Reduced 53.3%	61,104 $15,000
Q2 2022 Aug 12, 2022	BUY	$0.36 - $0.74 $6,598 - $13,563	18,329 Added 16.29%	130,852 $56,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.7 $54,973 - $155,759	91,623 Added 438.39%	112,523 $78,000
Q4 2021 Feb 11, 2022	BUY	$1.63 - $4.28 $34,067 - $89,452	20,900 New	20,900 $34,000

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.